MedPath

Acceptability of Human Papillomavirus (HPV) Self-sampling Tools for Cervical Cancer Prevention

Not Applicable
Terminated
Conditions
Cervical Cancer
Interventions
Diagnostic Test: HPV self-sampling kit
Behavioral: Fear Appeal Message
Behavioral: Culturally-targeted Fear Appeal Message
Behavioral: Interview
Registration Number
NCT03613493
Lead Sponsor
University of Miami
Brief Summary

The proposed study aims to increase HPV screening behaviors in Jamaican women by examining the acceptability of HPV Deoxyribonucleic Acid (DNA) self-sampling tools, and to determine the most culturally appropriate and effective message design for promoting such a tool in this context.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
175
Inclusion Criteria
  • Jamaican women, aged 30 to 65.
Read More
Exclusion Criteria
  • Women who report having had a hysterectomy,
  • have had a history of cervical cancer,
  • Women who are currently up-to-date on cervical cancer screening (have had a Pap in the last 3 years or have had a Pap smear/HPV co-test within the past 5 years),
  • Adults unable to consent, children, pregnant women and prisoners.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Culturally-targeted Fear appeal message HPV self-sampling kitHPV self-sampling kitParticipants will receive an HPV self-sampling kit to screen for HPV, accompanied by a culturally-targeted fear appeal message
Fear appeal message HPV self-sampling kitHPV self-sampling kitParticipants will receive an HPV self-sampling kit to screen for HPV, accompanied by a culturally-targeted fear appeal message
HPV self-sampling kit + InterviewHPV self-sampling kitParticipants will receive an HPV self-sampling kit to screen for HPV and then are interviewed about their experience using the tool.
Fear appeal message HPV self-sampling kitFear Appeal MessageParticipants will receive an HPV self-sampling kit to screen for HPV, accompanied by a culturally-targeted fear appeal message
HPV self-sampling kitHPV self-sampling kitParticipants will receive an HPV self-sampling kit to screen for HPV
Culturally-targeted Fear appeal message HPV self-sampling kitCulturally-targeted Fear Appeal MessageParticipants will receive an HPV self-sampling kit to screen for HPV, accompanied by a culturally-targeted fear appeal message
HPV self-sampling kit + InterviewInterviewParticipants will receive an HPV self-sampling kit to screen for HPV and then are interviewed about their experience using the tool.
Primary Outcome Measures
NameTimeMethod
Number of Participants That Used and Returned Their Self-sampler Kit.2 weeks

Number of participants that used and returned their self-sampler kit was evaluated.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Miami

🇺🇸

Miami, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath